Cardiac Assessment and Takotsubo-stunning Among COPD-exacerbations In-Hospital

Launched by SAHLGRENSKA UNIVERSITY HOSPITAL · Sep 12, 2024

Keywords

ClinConnect Summary

This clinical trial, called "Catching and Assessing Takotsubo-stunning Among COPD-exacerbations In-Hospital," is looking at how sudden worsening of Chronic Obstructive Pulmonary Disease (COPD) might lead to a heart condition known as Takotsubo-stunning. This condition can cause heart muscle weakening, similar to a heart attack, and understanding its impact on patients with COPD who are hospitalized is important. The study aims to find out how common this heart issue is in patients admitted for COPD flare-ups and whether those with Takotsubo-stunning experience more severe heart problems while in the hospital compared to those who do not have this condition.

To participate in this study, you need to be an adult, at least 18 years old, and currently hospitalized for a sudden worsening of COPD. You would need to give your consent to join within 72 hours of being admitted. The trial is currently recruiting participants, and it includes both men and women. If you decide to participate, you will help researchers learn more about these conditions and potentially improve care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients (≥ 18 years old) admitted to hospital ward for AE-COPD
• • Inclusion within 72 hours of admission,
• • Written informed consent
• Exclusion Criteria:
• • Prior acute myocardial infarction or known pre-existing persistent regional wall motion abnormality or left ventricular dysfunction (left ventricular ejection fraction \[LVEF\] \<50%)
• • Expected inability to comply with the protocol (e.g. dementia)